Fate Therapeutics Dividend
Dividend criteria checks 0/6
Fate Therapeutics does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Payout ratio
Industry average yield | 1.8% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Earnings per share | -€1.41 |
Dividend yield forecast in 3Y | 0% |
Recent dividend updates
No updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if F6T's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if F6T's dividend payments have been increasing.
Dividend Yield vs Market
Fate Therapeutics Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (F6T) | n/a |
Market Bottom 25% (DE) | 1.6% |
Market Top 25% (DE) | 4.7% |
Industry Average (Biotechs) | 1.8% |
Analyst forecast in 3 Years (F6T) | 0% |
Notable Dividend: Unable to evaluate F6T's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate F6T's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate F6T's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as F6T has not reported any payouts.